Search details
1.
Hidden tricks in MATH: Hypermorphic mutations in SPOP tumor suppressor explained by cryo-EM.
Mol Cell
; 83(5): 655-656, 2023 03 02.
Article
in English
| MEDLINE | ID: mdl-36868187
2.
Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
Prostate
; 84(3): 237-244, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37899635
3.
An evaluation of the effect of lithium on taxane-induced neuropathy.
Support Care Cancer
; 31(5): 299, 2023 Apr 25.
Article
in English
| MEDLINE | ID: mdl-37097406
4.
Rational Second-Generation Antiandrogen Use in Prostate Cancer.
Oncologist
; 27(2): 110-124, 2022 03 04.
Article
in English
| MEDLINE | ID: mdl-35641216
5.
Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer.
BMC Urol
; 22(1): 90, 2022 Jun 24.
Article
in English
| MEDLINE | ID: mdl-35751046
6.
Chemotherapy with atezolizumab for small cell or neuroendocrine carcinoma of the prostate: A single institution experience.
Prostate
; 81(13): 938-943, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34254332
7.
Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.
Clin Immunol
; 169: 58-68, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27237127
8.
CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.
BJU Int
; 128(1): 29-32, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33455021
9.
The yin and yang of chromosomal instability in prostate cancer.
Nat Rev Urol
; 21(6): 357-372, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38307951
10.
Reversibility of Bicalutamide PSMA PET-Positive Gynecomastia With Androgen Deprivation Therapy.
Clin Nucl Med
; 49(4): e164-e165, 2024 Apr 01.
Article
in English
| MEDLINE | ID: mdl-38377363
11.
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Prostate Cancer Prostatic Dis
; 2024 Feb 10.
Article
in English
| MEDLINE | ID: mdl-38341460
12.
Low PSA radiographic disease progression on C11-choline PET.
BJUI Compass
; 5(2): 319-324, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38371200
13.
MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
Neurol Neuroimmunol Neuroinflamm
; 11(4): e200249, 2024 Jul.
Article
in English
| MEDLINE | ID: mdl-38696737
14.
Theranostics and artificial intelligence: new frontiers in personalized medicine.
Theranostics
; 14(6): 2367-2378, 2024.
Article
in English
| MEDLINE | ID: mdl-38646652
15.
Salivary toxicity from PSMA-targeted radiopharmaceuticals: What we have learned and where we are going.
Cancer Treat Rev
; 127: 102748, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38703593
16.
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies.
Cancer Res Commun
; 4(5): 1369-1379, 2024 May 30.
Article
in English
| MEDLINE | ID: mdl-38709075
17.
SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors.
Cancer Res
; 83(6): 875-889, 2023 03 15.
Article
in English
| MEDLINE | ID: mdl-36637424
18.
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Clin Lung Cancer
; 24(8): 689-695.e1, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37880074
19.
Salvage therapy expands highly cytotoxic and metabolically fit resilient CD8+ T cells via ME1 up-regulation.
Sci Adv
; 9(46): eadi2414, 2023 11 17.
Article
in English
| MEDLINE | ID: mdl-37967193
20.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Article
in English
| MEDLINE | ID: mdl-38072760